ArticleMaterials today. Bio2025

Simultaneous induction of immunogenic cell death and PD-L1 downregulation by bufalin-based nanovaccines for potentiate HCC immunotherapy.

Zhe Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.